and lack of correlative laboratory data. While the sample size was small, the authors noted that given the rarity of patients with CNS myeloma involvement who successfully receive CAR T-cell ...

Craig Emmitt Cole, M.D. is a board-certified Hematologist who received his Bachelor of Science degree in physiology at ...

An elderly patient who was initially suspected of having antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) was instead diagnosed with multiple myeloma, according to a case report ...

Dr. Clark went on to explain to Hart that there was a significant therapeutic advancement in 2017 for the treatment of blood cancers like multiple myeloma with the FDA approval of what is known as ...

The unraveling of Marc and Alain Cohens' relationship with Dana-Farber — where Marc was also a trustee — has created possible ...

“Multiple myeloma is a type of cancer that affects plasma ... from a patient [with a specialized process] and send them to a lab where they are genetically modified to recognize cancer cells ...

A multi-peptide neoantigen cancer vaccine using relatively few antigens induced a strong immune response across multiple ...

In commemoration of the World Myeloma Action month ... management and further establish the mechanism of action in the laboratory”.

CRISPR technique can target single genes essential for cancer cell survival, toppling the whole structure, says nanomedicine ...

Based on internal projections for demand, the two companies have approved about $150 million in additional investments to ...

American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

A multiple myeloma treatment offers hope, but has a high cost. A Houston trial aims to make this life-saving therapy accessible.